Science Explorer Back to mapMap
Discussion
Company · Brookline · United States

Yuma Therapeutics (United States)

yumatherapeutics.comROR OpenAlex
Research works
1
fractional, all time
Citations
0
0.0 per fractional work
Top-10% rate
10.0%
all institutions 10.0%
Open access
9%
world 40%
International
9%
world 18%
Yuma Therapeutics (United States)

Not ranked overall: Yuma Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Yuma Therapeutics (United States) work in?

In all years, 64% of research at Yuma Therapeutics (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (18%), Neuroscience (18%).

Health Sciences: 1 fractional works · 63.6% of its workMedicine: 1 fractional works · 63.6% of its workLife Sciences: 0 fractional works · 36.4% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 18.2% of its workNeuroscience: 0 fractional works · 18.2% of its workALL ITS WORKYuma Therapeutics(United States)1fractional works, all years
Life Sciences36%Health Sciences64%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Medicine163.6%
    1. Biochemistry, Genetics and Molecular Biology018.2%
    2. Neuroscience018.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Which research topics does Yuma Therapeutics (United States) publish most on?

By volume in 2022-now: Cardiac Ischemia and Reperfusion, Cardiac Fibrosis and Remodeling, Signaling Pathways in Disease and Boron Compounds in Chemistry.

Cardiac Ischemia and Rep…0Cardiac Ischemia and Reperfusion: 0 fractional worksCardiac Fibrosis and Remodeling: 0 fractional worksSignaling Pathways in Disease: 0 fractional worksBoron Compounds in Chemistry: 0 fractional worksAnesthesia and Neurotoxicity Research: 0 fractional works
Pathology and Forensic MedicineCardiology and Cardiovascular MedicineMolecular BiologyRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cardiac Ischemia and Reperfusion Pathology and Forensic Medicine 0 works
  2. 2 Cardiac Fibrosis and Remodeling Cardiology and Cardiovascular Medicine 0 works
  3. 3 Signaling Pathways in Disease Molecular Biology 0 works
  4. 4 Boron Compounds in Chemistry Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Anesthesia and Neurotoxicity Research Developmental Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available9.1%not open90.9%

World: 40% of research is openly available.

with international co-authors9.1%domestic only90.9%

World: 18% is written across borders.

Other research institutions in Brookline

All research institutions in Brookline

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Yuma Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.